BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wasley A, Fiore A, Bell BP. Hepatitis A in the era of vaccination. Epidemiol Rev. 2006;28:101-111. [PMID: 16775039 DOI: 10.1093/epirev/mxj012] [Cited by in Crossref: 169] [Cited by in F6Publishing: 129] [Article Influence: 10.6] [Reference Citation Analysis]
Number Citing Articles
1 Plotkin SL, Plotkin SA. A short history of vaccination. Vaccines. Elsevier; 2013. pp. 1-13. [DOI: 10.1016/b978-1-4557-0090-5.00017-3] [Cited by in Crossref: 39] [Article Influence: 4.3] [Reference Citation Analysis]
2 Bernal W, Auzinger G, Dhawan A, Wendon J. Acute liver failure. Lancet. 2010;376:190-201. [PMID: 20638564 DOI: 10.1016/s0140-6736(10)60274-7] [Cited by in Crossref: 614] [Cited by in F6Publishing: 265] [Article Influence: 51.2] [Reference Citation Analysis]
3 Godoy P, Carmona G, Manzanares S, Jane M, Borràs E, Camps N, Álvarez J, Barrabeig I, Sala MR, Rius C, Minguell S, Carol M, Ferras J, Domínguez A; Working Group for the Study of Hepatitis in Catalonia. Trends and risk factors of hepatitis A in Catalonia after the introduction of a hepatitis A+B vaccination programme. J Viral Hepat 2018;25:1001-7. [PMID: 29603832 DOI: 10.1111/jvh.12900] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
4 Weston AL, Enger KS. Factors associated with hepatitis A vaccination receipt in one-year-olds in the state of Michigan. J Biomed Biotechnol 2010;2010:360652. [PMID: 20037733 DOI: 10.1155/2010/360652] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
5 Silva HC Junior, Pestana CP, Galler R, Medeiros MA. Solubility as a limiting factor for expression of hepatitis A virus proteins in insect cell-baculovirus system. Mem Inst Oswaldo Cruz 2016;111:535-8. [PMID: 27581123 DOI: 10.1590/0074-02760160153] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
6 Plotkin SL, Plotkin SA. A short history of vaccination. Vaccines. Elsevier; 2008. pp. 1-16. [DOI: 10.1016/b978-1-4160-3611-1.50005-2] [Cited by in Crossref: 7] [Article Influence: 0.5] [Reference Citation Analysis]
7 Donnelly MC, Davidson JS, Martin K, Baird A, Hayes PC, Simpson KJ. Acute liver failure in Scotland: changes in aetiology and outcomes over time (the Scottish Look-Back Study). Aliment Pharmacol Ther. 2017;45:833-843. [PMID: 28097670 DOI: 10.1111/apt.13943] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
8 Shin SY, Jeong SH, Sung PS, Lee J, Kim HJ, Lee HW, Shin EC. Comparative Analysis of Liver Injury-Associated Cytokines in Acute Hepatitis A and B. Yonsei Med J 2016;57:652-7. [PMID: 26996565 DOI: 10.3349/ymj.2016.57.3.652] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
9 Safiabadi M, Rezaee-zavareh MS, Moayed Alavian S. Estimation of Hepatitis A Virus Infection Prevalence Among Eastern Mediterranean and Middle Eastern Countries: A Systematic Review and Pooled Analysis. Hepat Mon 2017;17. [DOI: 10.5812/hepatmon.44695] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 2.2] [Reference Citation Analysis]
10 Ayouni K, Kharroubi G, Mallekh R, Hammami W, Marouani R, Mhamdi M, Ben Salah A, Triki H, Bettaieb J. Seroprevalence of hepatitis A virus infection in Central-West of Tunisia. J Med Virol 2021;93:3666-71. [PMID: 32986240 DOI: 10.1002/jmv.26563] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Chen H, Wang W, Wang S, Hu Y. Near-Complete Genome Sequence of a Hepatitis A Subgenotype IB Virus Isolated from Frozen Raspberries. Microbiol Resour Announc 2019;8:e00522-19. [PMID: 31270195 DOI: 10.1128/MRA.00522-19] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
12 Bender D, Glitscher M, Hildt E. [Viral hepatitis A to E: prevalence, pathogen characteristics, and pathogenesis]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2021. [PMID: 34932130 DOI: 10.1007/s00103-021-03472-0] [Reference Citation Analysis]
13 Hey P, Hanrahan TP, Sinclair M, Testro AG, Angus PW, Peterson A, Warrillow S, Bellomo R, Perini MV, Starkey G, Jones RM, Fink M, McClure T, Gow P. Epidemiology and outcomes of acute liver failure in Australia. World J Hepatol 2019; 11(7): 586-595 [PMID: 31388400 DOI: 10.4254/wjh.v11.i7.586] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
14 Anand AC, Nandi B, Acharya SK, Arora A, Babu S, Batra Y, Chawla YK, Chowdhury A, Chaoudhuri A, Eapen EC, Devarbhavi H, Dhiman R, Datta Gupta S, Duseja A, Jothimani D, Kapoor D, Kar P, Khuroo MS, Kumar A, Madan K, Mallick B, Maiwall R, Mohan N, Nagral A, Nath P, Panigrahi SC, Pawar A, Philips CA, Prahraj D, Puri P, Rastogi A, Saraswat VA, Saigal S, Shalimar, Shukla A, Singh SP, Verghese T, Wadhawan M; INASL Task-Force on Acute Liver Failure. Indian National Association for the Study of the Liver Consensus Statement on Acute Liver Failure (Part 1): Epidemiology, Pathogenesis, Presentation and Prognosis. J Clin Exp Hepatol 2020;10:339-76. [PMID: 32655238 DOI: 10.1016/j.jceh.2020.04.012] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 5.5] [Reference Citation Analysis]
15 Flefel EM, Tantawy WA, El-Sofany WI, El-Shahat M, El-Sayed AA, Abd-Elshafy DN. Synthesis of Some New Pyridazine Derivatives for Anti-HAV Evaluation. Molecules 2017;22:E148. [PMID: 28106751 DOI: 10.3390/molecules22010148] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
16 Shiukhi S, Elikaei A, Sharifi Z. The Prevalence of Hepatitis A Among Blood Donors in Golestan Province in the Northeast of Iran. Hepat Mon 2018;18. [DOI: 10.5812/hepatmon.81609] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
17 Debing Y, Kaplan GG, Neyts J, Jochmans D. Rapid and convenient assays to assess potential inhibitory activity on in vitro hepatitis A replication. Antiviral Res 2013;98:325-31. [PMID: 23528258 DOI: 10.1016/j.antiviral.2013.03.016] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
18 Gonçalves G. Herd immunity: recent uses in vaccine assessment. Expert Rev Vaccines 2008;7:1493-506. [PMID: 19053206 DOI: 10.1586/14760584.7.10.1493] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
19 Ayouni K, Chouikha A, Khamessi O, Touzi H, Hammemi W, Triki H. Evidence of Circulation of Several HAV Genetic Variants and Emergence of Potential Antigenic Variants in an Endemo-Epidemic Country before Vaccine Introduction. Viruses 2021;13:1056. [PMID: 34204862 DOI: 10.3390/v13061056] [Reference Citation Analysis]
20 Mayorga Perez O, Brinkhof MW, Egger M, Frösner G, Herzog C, Zwahlen M. Decreasing risk of hepatitis A infection in León, Nicaragua: evidence from cross-sectional and longitudinal seroepidemiology studies. PLoS One 2014;9:e87643. [PMID: 24523871 DOI: 10.1371/journal.pone.0087643] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
21 Patterson J, Abdullahi L, Hussey GD, Muloiwa R, Kagina BM. A systematic review of the epidemiology of hepatitis A in Africa. BMC Infect Dis 2019;19:651. [PMID: 31331281 DOI: 10.1186/s12879-019-4235-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
22 Pedersini R, Marano C, De Moerlooze L, Chen L, Vietri J. HAV & HBV vaccination among travellers participating in the National Health and Wellness Survey in five European countries. Travel Med Infect Dis. 2016;14:221-232. [PMID: 27000975 DOI: 10.1016/j.tmaid.2016.03.008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
23 Luquero FJ, Vallejo F, Fuente Lde L, Toro C, Brugal MT, Bravo MJ, Soriano V, Barrio G, Pulido J; Project Itinere Group. The role of injection versus socioeconomic factors in hepatitis A virus infection among young heroin users: Implications for vaccination policies. Vaccine 2009;27:2674-9. [PMID: 19428878 DOI: 10.1016/j.vaccine.2009.02.056] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
24 Heywood AE, Newall AT, Gao Z, Wood JG, Breschkin A, Nicholson S, Gidding HF, Dwyer DE, Gilbert GL, Macintyre CR. Changes in seroprevalence to hepatitis A in Victoria, Australia: a comparison of three time points. Vaccine 2012;30:6020-6. [PMID: 22867722 DOI: 10.1016/j.vaccine.2012.07.058] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
25 Begde F, Orhon FS, Gerceker D, Ulukol B, Topcu S, Baskan S. Determining the persistence of maternally acquired antibodies to hepatitis A and varicella zoster during the first 2 years of life in Turkey. Eur J Pediatr 2015;174:883-90. [DOI: 10.1007/s00431-014-2484-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
26 Barreto ML, Teixeira MG, Bastos FI, Ximenes RA, Barata RB, Rodrigues LC. Successes and failures in the control of infectious diseases in Brazil: social and environmental context, policies, interventions, and research needs. The Lancet 2011;377:1877-89. [DOI: 10.1016/s0140-6736(11)60202-x] [Cited by in Crossref: 173] [Cited by in F6Publishing: 75] [Article Influence: 15.7] [Reference Citation Analysis]
27 Vijayan V. Vaccines for International Pediatric Travelers. Pediatr Clin North Am 2022;69:171-84. [PMID: 34794673 DOI: 10.1016/j.pcl.2021.08.009] [Reference Citation Analysis]
28 Franco E, Meleleo C, Serino L, Sorbara D, Zaratti L. Hepatitis A: Epidemiology and prevention in developing countries. World J Hepatol 2012; 4(3): 68-73 [PMID: 22489258 DOI: 10.4254/wjh.v4.i3.68] [Cited by in Crossref: 157] [Cited by in F6Publishing: 112] [Article Influence: 15.7] [Reference Citation Analysis]
29 Hoseini SG, Kelishadi R, Ataei B, Yaran M, Motlagh ME, Ardalan G, Tajadini MH, Mostafavi SN. Seroprevalence of hepatitis A in Iranian adolescents: is it time to introduce a vaccine? Epidemiol Infect 2016;144:291-6. [PMID: 26083105 DOI: 10.1017/S0950268815001302] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 1.6] [Reference Citation Analysis]
30 Domínguez A, Oviedo M, Carmona G, Batalla J, Bruguera M, Salleras L, Plasència A. Impact and effectiveness of a mass hepatitis A vaccination programme of preadolescents seven years after introduction. Vaccine 2008;26:1737-41. [DOI: 10.1016/j.vaccine.2008.01.048] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 2.9] [Reference Citation Analysis]
31 Nguyen CT, Tran TT. Hepatitis vaccination and prophylaxis. Clin Liver Dis. 2009;13:317-329. [PMID: 19442921 DOI: 10.1016/j.cld.2009.02.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
32 Michos A, Terzidis A, Kalampoki V, Pantelakis K, Spanos T, Petridou ET. Seroprevalence and risk factors for hepatitis A, B, and C among Roma and non-Roma children in a deprived area of Athens, Greece. J Med Virol. 2008;80:791-797. [PMID: 18360892 DOI: 10.1002/jmv.21134] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
33 Bovier PA, Bock J, Ebengo TF, Frösner G, Glaus J, Herzog C, Loutan L. Predicted 30-year protection after vaccination with an aluminum-free virosomal hepatitis A vaccine. J Med Virol 2010;82:1629-34. [DOI: 10.1002/jmv.21883] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 3.2] [Reference Citation Analysis]
34 Lazcano-Ponce E, Conde-Gonzalez C, Rojas R, DeAntonio R, Romano-Mazzotti L, Cervantes Y, Ortega-Barria E. Seroprevalence of hepatitis A virus in a cross-sectional study in Mexico: Implications for hepatitis A vaccination. Hum Vaccin Immunother 2013;9:375-81. [PMID: 23291940 DOI: 10.4161/hv.22774] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
35 Hamza H, Abd-Elshafy DN, Fayed SA, Bahgat MM, El-Esnawy NA, Abdel-Mobdy E. Detection and characterization of hepatitis A virus circulating in Egypt. Arch Virol 2017;162:1921-31. [PMID: 28303345 DOI: 10.1007/s00705-017-3294-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
36 Wu D, Guo CY. Epidemiology and prevention of hepatitis A in travelers. J Travel Med 2013;20:394-9. [PMID: 24165384 DOI: 10.1111/jtm.12058] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
37 Thuluva S, Matur R, Tsa K, Gv SR. A single blind randomized phase 3 study to evaluate safety and immunogenicity of inactivated hepatitis A vaccine (HAPIBEVTM) in 1-15 years-old healthy hepatitis A vaccine-naïve children. Vaccine 2021;39:7166-74. [PMID: 34763950 DOI: 10.1016/j.vaccine.2021.10.018] [Reference Citation Analysis]
38 Manka P, Verheyen J, Gerken G, Canbay A. Liver Failure due to Acute Viral Hepatitis (A-E). Visc Med 2016;32:80-5. [PMID: 27413724 DOI: 10.1159/000444915] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
39 Jayakumar S, Chowdhury R, Ye C, Karvellas CJ. Fulminant viral hepatitis. Crit Care Clin. 2013;29:677-697. [PMID: 23830658 DOI: 10.1016/j.ccc.2013.03.013] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
40 Montrief T, Koyfman A, Long B. Acute liver failure: A review for emergency physicians. Am J Emerg Med 2019;37:329-37. [PMID: 30414744 DOI: 10.1016/j.ajem.2018.10.032] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
41 Jaykus L, Escudero-abarca B. Human Pathogenic Viruses in Food. In: Juneja VK, Sofos JN, editors. Pathogens and Toxins in Foods. Washington: ASM Press; 2009. pp. 218-32. [DOI: 10.1128/9781555815936.ch14] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
42 Ogefere HO, Egbe CA. Seroprevalence of IgM antibodies to hepatitis A virus in at-risk group in Benin City, Nigeria. Libyan J Med 2016;11:31290. [PMID: 27106172 DOI: 10.3402/ljm.v11.31290] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
43 Ayouni K, Naffeti B, Ben Aribi W, Bettaieb J, Hammami W, Ben Salah A, Ammar H, Ben Miled S, Triki H. Hepatitis a virus infection in Central-West Tunisia: an age structured model of transmission and vaccination impact. BMC Infect Dis 2020;20:627. [PMID: 32842988 DOI: 10.1186/s12879-020-05318-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
44 Cao G, Jing W, Liu J, Liu M. The global trends and regional differences in incidence and mortality of hepatitis A from 1990 to 2019 and implications for its prevention. Hepatol Int 2021. [PMID: 34345993 DOI: 10.1007/s12072-021-10232-4] [Reference Citation Analysis]
45 Elufioye TO, Habtemariam S. Hepatoprotective effects of rosmarinic acid: Insight into its mechanisms of action. Biomedicine & Pharmacotherapy 2019;112:108600. [DOI: 10.1016/j.biopha.2019.108600] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 7.7] [Reference Citation Analysis]
46 Vaughan G, Forbi JC, Xia G, Fonseca-ford M, Vazquez R, Khudyakov YE, Montiel S, Waterman S, Alpuche C, Gonçalves Rossi LM, Luna N. Full-length genome characterization and genetic relatedness analysis of hepatitis A virus outbreak strains associated with acute liver failure among children: Fulminant Hepatitis A Virus among Children. J Med Virol 2014;86:202-8. [DOI: 10.1002/jmv.23843] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
47 Aldea Novo M, Bayas Rodríguez J, Moraga-llop F. Programas de vacunación universal contra la hepatitis A en el mundo. Vacunas 2012;13:150-62. [DOI: 10.1016/s1576-9887(12)70057-2] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
48 Ahmad F, Hamzah NAC, Mustaffa N, Gan SH. Anti-hepatitis A seroprevalence among chronic viral hepatitis patients in Kelantan, Malaysia. World J Gastroenterol 2011; 17(36): 4130-4134 [PMID: 22039329 DOI: 10.3748/wjg.v17.i36.4130] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
49 Snooks MJ, Bhat P, Mackenzie J, Counihan NA, Vaughan N, Anderson DA. Vectorial entry and release of hepatitis A virus in polarized human hepatocytes. J Virol. 2008;82:8733-8742. [PMID: 18579610 DOI: 10.1128/jvi.00219-08] [Cited by in Crossref: 30] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
50 Chauhan S, Agarwal J, Jain A, Sawlani KK, Gupta P, Goel A, Verma N, Himanshu D. Status of adult immunity to hepatitis A virus in healthcare workers from a tertiary care hospital in north India. Indian J Med Res 2019;150:508-11. [PMID: 31939396 DOI: 10.4103/ijmr.IJMR_787_18] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
51 Raghavan RS, Barath J, Narayanan P, Deepak R, Mahadevan S. CSF PCR in a child with parainfectious myelopathy associated with HVA infection. J Pediatr Gastroenterol Nutr 2014;58:e46-7. [PMID: 24792634 DOI: 10.1097/MPG.0b013e3182779ebb] [Reference Citation Analysis]
52 Plotkin SL, Plotkin SA. A Short History of Vaccination. Plotkin's Vaccines. Elsevier; 2018. pp. 1-15.e8. [DOI: 10.1016/b978-0-323-35761-6.00001-8] [Cited by in Crossref: 13] [Article Influence: 3.3] [Reference Citation Analysis]
53 Anonychuk AM, Tricco AC, Bauch CT, Pham B, Gilca V, Duval B, John-Baptiste A, Woo G, Krahn M. Cost-effectiveness analyses of hepatitis A vaccine: a systematic review to explore the effect of methodological quality on the economic attractiveness of vaccination strategies. Pharmacoeconomics 2008;26:17-32. [PMID: 18088156 DOI: 10.2165/00019053-200826010-00003] [Cited by in Crossref: 44] [Cited by in F6Publishing: 35] [Article Influence: 3.1] [Reference Citation Analysis]
54 Foti D, Cavallo D. Mechanical behavior of concretes made with non-conventional organic origin calcareous aggregates. Construction and Building Materials 2018;179:100-6. [DOI: 10.1016/j.conbuildmat.2018.05.042] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 3.3] [Reference Citation Analysis]
55 Karimi A, Mortazaei S, Moradi MT. High Prevalence of Symptomatic Hepatitis A Infection in Rural Area of Chaharmahal VA Bakhtiari Province, Iran. J Clin Diagn Res 2015;9:DC01-3. [PMID: 25859451 DOI: 10.7860/JCDR/2015/9798.5515] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
56 Van Herck K, Jacquet JM, Van Damme P. Antibody persistence and immune memory in healthy adults following vaccination with a two-dose inactivated hepatitis A vaccine: long-term follow-up at 15 years. J Med Virol 2011;83:1885-91. [PMID: 21915861 DOI: 10.1002/jmv.22200] [Cited by in Crossref: 36] [Cited by in F6Publishing: 28] [Article Influence: 3.3] [Reference Citation Analysis]
57 Stauft CB, Tegenge M, Khurana S, Lee Y, Selvaraj P, Golding H, Wang T, Golding B. Pharmacokinetics and Efficacy of Human Hyperimmune Intravenous Immunoglobulin Treatment of SARS-CoV-2 Infection in Adult Syrian Hamsters. Clin Infect Dis 2021:ciab854. [PMID: 34554235 DOI: 10.1093/cid/ciab854] [Reference Citation Analysis]
58 Mahboobi N, Porter SR, Karayiannis P, Alavian SM. Oral fluid and hepatitis A, B and C: a literature review. J Oral Pathol Med. 2012;41:505-516. [PMID: 22188507 DOI: 10.1111/j.1600-0714.2011.01123.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
59 Gözü Pirinççioğlu A, Adıgüzel S, Özekinci T. Seropositivity of Hepatitis A in Children Aged 7-14 Years in Diyarbakir Province Center. Med Sci Monit 2018;24:936-43. [PMID: 29445079 DOI: 10.12659/msm.906861] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
60 Najar M, Fayyad-Kazan H, Faour WH, El Taghdouini A, Raicevic G, Najimi M, Toungouz M, van Grunsven LA, Sokal E, Lagneaux L. Human hepatic stellate cells and inflammation: A regulated cytokine network balance. Cytokine 2017;90:130-4. [PMID: 27865205 DOI: 10.1016/j.cyto.2016.11.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
61 Ishii K, Kiyohara T, Yoshizaki S, Kawabata K, Kanayama A, Yahata Y, Takahashi T, Kinoshita H, Saitou T, Sunagawa T, Oishi K, Uema M, Noda M, Wakita T. Epidemiological and genetic analysis of a 2014 outbreak of hepatitis A in Japan. Vaccine 2015;33:6029-36. [PMID: 25957664 DOI: 10.1016/j.vaccine.2015.04.061] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
62 Smits SL, Koopmans MPG. Genomics and Foodborne Viral Infections. In: Deng X, den Bakker HC, Hendriksen RS, editors. Applied Genomics of Foodborne Pathogens. Cham: Springer International Publishing; 2017. pp. 145-66. [DOI: 10.1007/978-3-319-43751-4_9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
63 Rinderknecht S, Michaels MG, Blatter M, Gaglani M, Andrews W, Abughali N, Chandreshekaran V, Trofa AF. Immunogenicity and Safety of an Inactivated Hepatitis A Vaccine When Coadministered With Measles-mumps-rubella and Varicella Vaccines in Children Less Than 2 Years of Age. Pediatric Infectious Disease Journal 2011;30:e179-85. [DOI: 10.1097/inf.0b013e31822256a5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
64 Bihari C, Rastogi A, Sarin SK. Postinfantile giant cell hepatitis: an etiological and prognostic perspective. Hepat Res Treat. 2013;2013:601290. [PMID: 23555054 DOI: 10.1155/2013/601290] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
65 Moratorio G, Costa-mattioli M, Piovani R, Romero H, Musto H, Cristina J. Bayesian coalescent inference of hepatitis A virus populations: evolutionary rates and patterns. Journal of General Virology 2007;88:3039-42. [DOI: 10.1099/vir.0.83038-0] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 1.9] [Reference Citation Analysis]
66 Aasheim ET, Seymour M, Balogun K, Ngui SL, Williams CJ, Shankar AG. Acute hepatitis A in an elderly patient after care worker travel to high endemicity country. Hum Vaccin Immunother. 2013;9:2480-2482. [PMID: 23880980 DOI: 10.4161/hv.25719] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
67 Wang Z, Chen Y, Xie S, Lv H. Changing Epidemiological Characteristics of Hepatitis A in Zhejiang Province, China: Increased Susceptibility in Adults. PLoS One 2016;11:e0153804. [PMID: 27093614 DOI: 10.1371/journal.pone.0153804] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
68 Murphy TV, Denniston MM, Hill HA, McDonald M, Klevens MR, Elam-Evans LD, Nelson NP, Iskander J, Ward JD. Progress Toward Eliminating Hepatitis A Disease in the United States. MMWR Suppl 2016;65:29-41. [PMID: 26916458 DOI: 10.15585/mmwr.su6501a6] [Cited by in Crossref: 43] [Cited by in F6Publishing: 33] [Article Influence: 7.2] [Reference Citation Analysis]
69 Ahn JH, Chung JJ, Yu JS, Kim JH, Cho ES, Kim DJ. Prognostic value of gallbladder wall thickening in patients with acute hepatitis A. Ultrasonography 2015;34:139-43. [PMID: 25672770 DOI: 10.14366/usg.14052] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
70 Jacobsen KH, Wiersma ST. Hepatitis A virus seroprevalence by age and world region, 1990 and 2005. Vaccine. 2010;28:6653-6657. [PMID: 20723630 DOI: 10.1016/j.vaccine.2010.08.037] [Cited by in Crossref: 315] [Cited by in F6Publishing: 251] [Article Influence: 26.3] [Reference Citation Analysis]
71 Ma F, Yang J, Kang G, Sun Q, Lu P, Zhao Y, Wang Z, Luo J, Wang Z. Comparison of the safety and immunogenicity of live attenuated and inactivated hepatitis A vaccine in healthy Chinese children aged 18 months to 16 years: results from a randomized, parallel controlled, phase IV study. Clin Microbiol Infect 2016;22:811.e9-811.e15. [PMID: 27345175 DOI: 10.1016/j.cmi.2016.06.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
72 Al-Salahi R, Anouar EH, Marzouk M, Abuelizz HA. Anti-HAV evaluation and molecular docking of newly synthesized 3-benzyl(phenethyl)benzo[g]quinazolines. Bioorg Med Chem Lett 2019;29:1614-9. [PMID: 31054861 DOI: 10.1016/j.bmcl.2019.04.043] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
73 Epson EE, Cronquist A, Lamba K, Kimura AC, Hassan R, Selvage D, McNeil CS, Varan AK, Silvaggio JL, Fan L, Tong X, Spradling PR. Risk factors for hospitalisation and associated costs among patients with hepatitis A associated with imported pomegranate arils, United States, 2013. Public Health 2016;136:144-51. [PMID: 27156991 DOI: 10.1016/j.puhe.2016.03.027] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
74 Kim H, Ryu J, Lee YK, Choi MJ, Cho A, Koo JR, Baik SY, Lee EH, Yoon JW, Noh JW. Seropositive rate of the anti-hepatitis A immunoglobulin G antibody in maintenance hemodialysis subjects from two hospitals in Korea. Korean J Intern Med 2019;34:1297-303. [PMID: 29466851 DOI: 10.3904/kjim.2017.293] [Reference Citation Analysis]
75 Van Der Meeren O, Crasta P, de Ridder M. A retrospective pooled analysis assessing the effect of age on the immunogenicity of Havrix™ in healthy adults. Hum Vaccin Immunother 2015;11:1729-34. [PMID: 26029816 DOI: 10.1080/21645515.2015.1045167] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
76 Yun H, Lee HJ, Cheon D, Chu C, Oh KW, Kim YT, Jee Y. Seroprevalence of hepatitis a and e viruses based on the third Korea national health and nutrition survey in Korea. Osong Public Health Res Perspect 2011;2:46-50. [PMID: 24159450 DOI: 10.1016/j.phrp.2011.04.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
77 Melgaço JG, Pinto MA, Rocha AM, Freire M, Gaspar LP, Lima SM, Cruz OG, Vitral CL. The use of dried blood spots for assessing antibody response to hepatitis A virus after natural infection and vaccination. J Med Virol 2011;83:208-17. [PMID: 21181914 DOI: 10.1002/jmv.21973] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
78 Ishii K, Kiyohara T, Yoshizaki S, Wakita T, Shimada T, Nakamura N, Nakashima K, Tada Y, Noda M. Epidemiological and genetic analyses of a diffuse outbreak of hepatitis A in Japan, 2010. J Clin Virol 2012;53:219-24. [PMID: 22196871 DOI: 10.1016/j.jcv.2011.11.008] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
79 Moon HW, Cho JH, Hur M, Yun YM, Choe WH, Kwon SY, Lee CH. Laboratory characteristics of recent hepatitis A in Korea: Ongoing epidemiological shift. World J Gastroenterol 2010; 16(9): 1115-1118 [PMID: 20205283 DOI: 10.3748/wjg.v16.i9.1115] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
80 Kanyenda TJ, Abdullahi LH, Hussey GD, Kagina BM. Epidemiology of hepatitis A virus in Africa among persons aged 1-10 years: a systematic review protocol. Syst Rev 2015;4:129. [PMID: 26419360 DOI: 10.1186/s13643-015-0112-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
81 Draz MS, Shafiee H. Applications of gold nanoparticles in virus detection. Theranostics 2018;8:1985-2017. [PMID: 29556369 DOI: 10.7150/thno.23856] [Cited by in Crossref: 114] [Cited by in F6Publishing: 80] [Article Influence: 28.5] [Reference Citation Analysis]
82 Ogholikhan S, Schwarz KB. Hepatitis Vaccines. Vaccines (Basel). 2016;4:E6. [PMID: 26978406 DOI: 10.3390/vaccines4010006] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.7] [Reference Citation Analysis]
83 Oviedo M, Pilar Muñoz M, Domínguez A, Borras E, Carmona G. A statistical model to estimate the impact of a hepatitis A vaccination programme. Vaccine 2008;26:6157-64. [PMID: 18804511 DOI: 10.1016/j.vaccine.2008.08.066] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
84 Murphy TV, Feinstone SM, Bell BP. Hepatitis A vaccines. Vaccines. Elsevier; 2013. pp. 183-204. [DOI: 10.1016/b978-1-4557-0090-5.00008-2] [Cited by in Crossref: 9] [Article Influence: 1.0] [Reference Citation Analysis]
85 de Alencar Ximenes RA, Martelli CM, Merchán-Hamann E, Montarroyos UR, Braga MC, de Lima ML, Cardoso MR, Turchi MD, Costa MA, de Alencar LC, Moreira RC, Figueiredo GM, Pereira LM; Hepatitis Study Group. Multilevel analysis of hepatitis A infection in children and adolescents: a household survey in the Northeast and Central-west regions of Brazil. Int J Epidemiol 2008;37:852-61. [PMID: 18653514 DOI: 10.1093/ije/dyn114] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 3.1] [Reference Citation Analysis]
86 Vaughan G, Xia G, Forbi JC, Purdy MA, Rossi LM, Spradling PR, Khudyakov YE. Genetic relatedness among hepatitis A virus strains associated with food-borne outbreaks. PLoS One 2013;8:e74546. [PMID: 24223112 DOI: 10.1371/journal.pone.0074546] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
87 Teo CG. 19th-century and early 20th-century jaundice outbreaks, the USA. Epidemiol Infect 2018;146:138-46. [DOI: 10.1017/s0950268817002837] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
88 Lefton HB, Rosa A, Cohen M. Diagnosis and Epidemiology of Cirrhosis. Medical Clinics of North America 2009;93:787-99. [DOI: 10.1016/j.mcna.2009.03.002] [Cited by in Crossref: 59] [Cited by in F6Publishing: 52] [Article Influence: 4.5] [Reference Citation Analysis]
89 Paul RC, Nazneen A, Banik KC, Sumon SA, Paul KK, Akram A, Uzzaman MS, Iqbal T, Tejada-Strop A, Kamili S, Luby SP, Gidding HF, Hayen A, Gurley ES. Hepatitis E as a cause of adult hospitalization in Bangladesh: Results from an acute jaundice surveillance study in six tertiary hospitals, 2014-2017. PLoS Negl Trop Dis 2020;14:e0007586. [PMID: 31961861 DOI: 10.1371/journal.pntd.0007586] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
90 Ismail F, Alsharif F, El-Garawani I, Abdelsameea E. Acute Hepatitis A Virus Infection in Tobruk, Eastern Libya: Increasing Trends After 2017. Food Environ Virol 2021. [PMID: 34633604 DOI: 10.1007/s12560-021-09499-5] [Reference Citation Analysis]
91 La Rosa G, Mancini P, Bonanno Ferraro G, Iaconelli M, Veneri C, Paradiso R, De Medici D, Vicenza T, Proroga YTR, Di Maro O, Ciccaglione AR, Bruni R, Other Members Of The Nrl For Human Viral Hepatitis, Della Rotonda M, Suffredini E. Hepatitis A Virus Strains Circulating in the Campania Region (2015-2018) Assessed through Bivalve Biomonitoring and Environmental Surveillance. Viruses 2020;13:E16. [PMID: 33374859 DOI: 10.3390/v13010016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
92 Vaughan G, Goncalves Rossi LM, Forbi JC, de Paula VS, Purdy MA, Xia G, Khudyakov YE. Hepatitis A virus: host interactions, molecular epidemiology and evolution. Infect Genet Evol. 2014;21:227-243. [PMID: 24200587 DOI: 10.1016/j.meegid.2013.10.023] [Cited by in Crossref: 89] [Cited by in F6Publishing: 75] [Article Influence: 9.9] [Reference Citation Analysis]
93 Li C, Su H, Hu J, Duan H, Ji J. Case of severe acute hepatitis A virus infection in United Nations peacekeepers in South Sudan. J R Army Med Corps 2019;165:198-200. [PMID: 30012663 DOI: 10.1136/jramc-2018-000990] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
94 Dahanayaka NJ, Kiyohara T, Agampodi SB, Samaraweera PK, Kulasooriya GK, Ranasinghe JC, Semage SN, Yoshizaki S, Wakita T, Ishii K. Clinical features and transmission pattern of hepatitis A: An experience from a hepatitis A outbreak caused by two cocirculating genotypes in Sri Lanka. Am J Trop Med Hyg. 2016;95:908-914. [PMID: 27382079 DOI: 10.4269/ajtmh.16-0221] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
95 de Paula VS. Laboratory diagnosis of hepatitis A. Future Virology 2012;7:461-72. [DOI: 10.2217/fvl.12.35] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
96 Loader M, Moravek R, Witowski SE, Driscoll LM. A clinical review of viral hepatitis. Journal of the American Academy of Physician Assistants 2019;32:15-20. [DOI: 10.1097/01.jaa.0000586300.88300.84] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
97 Mena G, García-Basteiro AL, Bayas JM. Hepatitis B and A vaccination in HIV-infected adults: A review. Hum Vaccin Immunother 2015;11:2582-98. [PMID: 26208678 DOI: 10.1080/21645515.2015.1055424] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 6.1] [Reference Citation Analysis]
98 Castaneda D, Gonzalez AJ, Alomari M, Tandon K, Zervos XB. From hepatitis A to E: A critical review of viral hepatitis. World J Gastroenterol 2021; 27(16): 1691-1715 [PMID: 33967551 DOI: 10.3748/wjg.v27.i16.1691] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
99 Arteaga A, Carrasco-garrido P, de Andres AL, de Miguel ÁG, Jiménez-garcía R. Trends of hepatitis A hospitalizations and costs associated with the hospitalization in Spain (2000-2005). Journal of Viral Hepatitis 2009;16:286-91. [DOI: 10.1111/j.1365-2893.2009.01075.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
100 Cardenas A, Smit E, Bethel JW, Houseman EA, Kile ML. Arsenic exposure and the seroprevalence of total hepatitis A antibodies in the US population: NHANES, 2003-2012. Epidemiol Infect 2016;144:1641-51. [PMID: 26739255 DOI: 10.1017/S0950268815003088] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
101 Halicioglu O, Akman SA, Tatar B, Atesli R, Kose S. Hepatitis A seroprevalence in children and adolescents aged 1–18 years among a low socioeconomic population in Izmir, Turkey. Travel Medicine and Infectious Disease 2012;10:43-7. [DOI: 10.1016/j.tmaid.2012.01.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
102 Khounvisith V, Xaiyaphet X, Chanthavilay P, Nouanthong P, Vongphachanh B, Reinharz D, Muller CP, Black AP. Hepatitis A Virus in Lao People's Democratic Republic: Seroprevalence and Risk Factors. Am J Trop Med Hyg 2020;103:164-8. [PMID: 32342836 DOI: 10.4269/ajtmh.19-0451] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
103 Blechová Z, Trojánek M, Kynčl J, Částková J, John J, Malý M, Herrmannová K, Marešová V. Clinical and laboratory features of viral hepatitis A in children. Wien Klin Wochenschr 2013;125:83-90. [DOI: 10.1007/s00508-012-0316-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
104 Averhoff FM, Khudyakov Y, Nelson NP. Hepatitis A Vaccines. Plotkin's Vaccines. Elsevier; 2018. pp. 319-341.e15. [DOI: 10.1016/b978-0-323-35761-6.00024-9] [Cited by in Crossref: 6] [Article Influence: 1.5] [Reference Citation Analysis]
105 Xiang K, Kusov Y, Ying G, Yan W, Shan Y, Jinyuan W, Na Y, Yan Z, Hongjun L, Maosheng S. A Recombinant HAV Expressing a Neutralization Epitope of HEV Induces Immune Response against HAV and HEV in Mice. Viruses 2017;9:E260. [PMID: 28914805 DOI: 10.3390/v9090260] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
106 Lim J, Kim K, Choi S, Park SM. The effectiveness and limitation of the national childhood hepatitis A vaccination program in the Republic of Korea: Findings from the Korean National Health and Nutrition Examination Survey (KNHANES), 2015. PLoS One 2017;12:e0189210. [PMID: 29220416 DOI: 10.1371/journal.pone.0189210] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
107 Domínguez A, Oviedo M, Carmona G, Jansá JM, Borrás E, Salleras L, Plasència A. Epidemiology of hepatitis A before and after the introduction of a universal vaccination programme in Catalonia, Spain. J Viral Hepat 2008;15 Suppl 2:51-6. [PMID: 18837835 DOI: 10.1111/j.1365-2893.2008.01030.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
108 Koff RS. Review article: vaccination and viral hepatitis - current status and future prospects. Alimentary Pharmacology & Therapeutics 2007;26:1285-92. [DOI: 10.1111/j.1365-2036.2007.03517.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
109 Liu XE, Wushouer F, Gou A, Kuerban M, Li X, Sun Y, Zhang J, Liu Y, Li J, Zhuang H. Comparison of immunogenicity between inactivated and live attenuated hepatitis A vaccines: a single-blind, randomized, parallel-group clinical trial among children in Xinjiang Uighur Autonomous Region, China. Hum Vaccin Immunother 2013;9:1460-5. [PMID: 23571173 DOI: 10.4161/hv.24366] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
110 Brinkhof MW, Mayorga O, Bock J, Heininger U, Herzog C. Kinetics of maternally acquired anti-hepatitis A antibodies: prediction of waning based on maternal or cord blood antibody levels. Vaccine 2013;31:1490-5. [PMID: 23328312 DOI: 10.1016/j.vaccine.2013.01.011] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
111 Sellner J, Steiner I. Neurologic complications of hepatic viruses. Handb Clin Neurol 2014;123:647-61. [PMID: 25015509 DOI: 10.1016/B978-0-444-53488-0.00031-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
112 Thudi K, Yadav D, Sweeney K, Behari J. Physicians infrequently adhere to hepatitis vaccination guidelines for chronic liver disease. PLoS One 2013;8:e71124. [PMID: 23923056 DOI: 10.1371/journal.pone.0071124] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
113 Galor I, Hartal M, Perry Markovich M, Avramovich E. Population seroprotection against hepatitis a virus in Israel 18 years after introduction of inactivated vaccine into the routine childhood vaccination schedule: Response letter, to letter to the editor. Vaccine 2021;39:4777. [PMID: 34332696 DOI: 10.1016/j.vaccine.2021.07.008] [Reference Citation Analysis]
114 Minosse C, Messina F, Garbuglia AR, Meschi S, Scognamiglio P, Capobianchi MR, Ippolito G, Lanini S. Origin of HAV strains responsible for 2016-2017 outbreak among MSM: Viral phylodynamics in Lazio region. PLoS One 2020;15:e0234010. [PMID: 32470049 DOI: 10.1371/journal.pone.0234010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
115 Kul G, Tosun S, Alkan Çevıker S, Uzar H, Alay H, Kesmez Can F, Seremet Keskin A, Ceylan MR, Yıldız Kaya S, Aslan S; Multicenter Study Group. Evaluation of testing and vaccination status of healthcare workers in Turkey for hepatitis A: A multicenter study. Int J Clin Pract 2021;:e14700. [PMID: 34351665 DOI: 10.1111/ijcp.14700] [Reference Citation Analysis]
116 Ozawa S, Privor-dumm LA, Nanni A, Durden E, Maiese BA, Nwankwo CU, Brodovicz KG, Acosta CJ, Foley KA. Evidence-to-policy gap on hepatitis A vaccine adoption in 6 countries: Literature vs. policymakers’ beliefs. Vaccine 2014;32:4089-96. [DOI: 10.1016/j.vaccine.2014.05.026] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
117 Tsou T, Liu C, Huang J, Tsai K, Chang H. Change in hepatitis A epidemiology after vaccinating high risk children in Taiwan, 1995–2008. Vaccine 2011;29:2956-61. [DOI: 10.1016/j.vaccine.2011.02.001] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
118 Domínguez A, Bruguera M, Plans P, Espuñes J, Costa J, Plasencia A, Salleras L. Declining hepatitis A seroprevalence in adults in Catalonia (Spain): a population-based study. BMC Infect Dis 2007;7:73. [PMID: 17610736 DOI: 10.1186/1471-2334-7-73] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
119 Kulkarni MA, Walimbe AM, Cherian S, Arankalle VA. Full length genomes of genotype IIIA Hepatitis A Virus strains (1995-2008) from India and estimates of the evolutionary rates and ages. Infect Genet Evol 2009;9:1287-94. [PMID: 19723592 DOI: 10.1016/j.meegid.2009.08.009] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
120 Prasoppokakorn T, Vanichanan J, Chaiteerakij R, Jutivorakool K, Udomkarnjananun S, Pongpirul K, Taesombat W, Wattanatorn S, Avihingsanon Y, Tungsanga K, Eiam-Ong S, Praditpornsilpa K, Townamchai N. A randomized controlled trial of comparative effectiveness between the 2 dose and 3 dose regimens of hepatitis a vaccine in kidney transplant recipients. Sci Rep 2021;11:50. [PMID: 33420114 DOI: 10.1038/s41598-020-80052-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
121 Costas L, Vilella A, Trilla A, Serrano B, Vera I, Roldán M, Sancho M, Bayas J, Gascón J, Costa J. Vaccination Strategies Against Hepatitis A in Travelers Older Than 40 Years: An Economic Evaluation. J Travel Med 2009;16:344-8. [DOI: 10.1111/j.1708-8305.2009.00320.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
122 Satsangi S, Dhiman RK. Combating the wrath of viral hepatitis in India. Indian J Med Res 2016;144:1-5. [PMID: 27834318 DOI: 10.4103/0971-5916.193275] [Cited by in Crossref: 3] [Article Influence: 0.5] [Reference Citation Analysis]
123 Nothdurft HD. Hepatitis A vaccines. Expert Review of Vaccines 2014;7:535-45. [DOI: 10.1586/14760584.7.5.535] [Cited by in Crossref: 40] [Cited by in F6Publishing: 29] [Article Influence: 5.0] [Reference Citation Analysis]
124 Juniastuti, Wahyuddin D, Nihayatussa'adah, Amin M, Yamani LN, Utsumi T, Sustini F, Lusida MI. Analysis of genetic and serology of hepatitis A virus infection during and after outbreak in two junior high schools in Surabaya, Indonesia. J Med Virol 2019;91:1048-55. [PMID: 30659645 DOI: 10.1002/jmv.25403] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
125 Wu R, Xing X, Corredig M, Meng B, Griffiths MW. Concentration of hepatitis A virus in milk using protamine-coated iron oxide (Fe3O4) magnetic nanoparticles. Food Microbiol 2019;84:103236. [PMID: 31421754 DOI: 10.1016/j.fm.2019.05.020] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
126 Chi V, Cleary S, Bocchini JA Jr. In pursuit of control and elimination: update on hepatitis A and B epidemiology and prevention strategies. Curr Opin Pediatr 2018;30:689-97. [PMID: 30188873 DOI: 10.1097/MOP.0000000000000672] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
127 Stübgen JP. Neuromuscular complications of hepatitis A virus infection and vaccines. J Neurol Sci 2011;300:2-8. [PMID: 20920814 DOI: 10.1016/j.jns.2010.09.015] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
128 Watanabe S, Morimoto N, Miura K, Takaoka Y, Nomoto H, Tsukui M, Isoda N, Ohnishi H, Nagashima S, Takahashi M, Okamoto H, Yamamoto H. Full‐genome characterization of the RIVM‐HAV16‐090‐like hepatitis A virus strains recovered from Japanese men who have sex with men, with sporadic acute hepatitis A. Hepatol Res 2019;49:521-30. [DOI: 10.1111/hepr.13313] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
129 Wang Y, Xie X, Liu H, Liu H, Jiang H. LR12 Promotes Liver Repair by Improving the Resolution of Inflammation and Liver Regeneration in Mice with Thioacetamide- (TAA-) Induced Acute Liver Failure. Mediators Inflamm 2021;2021:2327721. [PMID: 34135689 DOI: 10.1155/2021/2327721] [Reference Citation Analysis]
130 Ji Y, Si W, Zeng J, Huang L, Huang Z, Zhao L, Liu J, Zhu M, Kuang W. Niujiaodihuang Detoxify Decoction inhibits ferroptosis by enhancing glutathione synthesis in acute liver failure models. J Ethnopharmacol 2021;279:114305. [PMID: 34129898 DOI: 10.1016/j.jep.2021.114305] [Reference Citation Analysis]
131 Quaglio G, Ramadani N, Pattaro C, Cami A, Dentico P, Volpe A, Pellizzer G, Berisha A, Smacchia C, Figliomeni M. Prevalence and risk factors for viral hepatitis in the Kosovarian population: implications for health policy. J Med Virol. 2008;80:833-840. [PMID: 18360897 DOI: 10.1002/jmv.21141] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
132 Murdaca G, Noberasco G, Olobardi D, Lunardi C, Maule M, Delfino L, Triggiani M, Cardamone C, Benfaremo D, Moroncini G, Vacca A, Susca N, Gangemi S, Quattrocchi P, Sticchi L, Icardi G, Orsi A. Current Take on Systemic Sclerosis Patients' Vaccination Recommendations. Vaccines (Basel) 2021;9:1426. [PMID: 34960174 DOI: 10.3390/vaccines9121426] [Reference Citation Analysis]
133 Yun H, Lee HJ, Yoon Y, Kim K, Kim S, Shin MH, Taniguchi M, Kim SR, Kim MK. Seroepidemiology of hepatitis a infection in northeastern china, Korea, and Japan. Osong Public Health Res Perspect 2012;3:31-5. [PMID: 24159484 DOI: 10.1016/j.phrp.2012.01.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
134 Takahashi M, Okakura Y, Takahashi H, Imamura M, Takeuchi A, Shidara H, Kuda T, Kimura B. Heat-denatured lysozyme could be a novel disinfectant for reducing hepatitis A virus and murine norovirus on berry fruit. Int J Food Microbiol 2018;266:104-8. [PMID: 29202339 DOI: 10.1016/j.ijfoodmicro.2017.11.017] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
135 Nelson NP, Murphy TV. Hepatitis A: The changing epidemiology of hepatitis A. Clin Liver Dis (Hoboken). 2013;2:227-230. [PMID: 26566433 DOI: 10.1002/cld.230] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
136 Stübgen JP. Immune-mediated myelitis associated with hepatitis virus infections. J Neuroimmunol. 2011;239:21-27. [PMID: 21945641 DOI: 10.1016/j.jneuroim.2011.09.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
137 Denniston MM, Monina Klevens R, Jiles RB, Murphy TV. Self-reported hepatitis A vaccination as a predictor of hepatitis A virus antibody protection in U.S. adults: National Health and Nutrition Examination Survey 2007-2012. Vaccine 2015;33:3887-93. [PMID: 26116252 DOI: 10.1016/j.vaccine.2015.06.063] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
138 Hartard C, Gantzer C, Bronowicki JP, Schvoerer E. Emerging hepatitis E virus compared with hepatitis A virus: A new sanitary challenge. Rev Med Virol 2019;29:e2078. [PMID: 31456241 DOI: 10.1002/rmv.2078] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
139 Melhem NM, Talhouk R, Rachidi H, Ramia S. Hepatitis A virus in the Middle East and North Africa region: a new challenge. J Viral Hepat 2014;21:605-15. [DOI: 10.1111/jvh.12282] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 3.5] [Reference Citation Analysis]
140 Stein-zamir C, Shoob H, Nubani N, Zentner G. Hepatitis A in Jerusalem—The exception that proves the rule? Vaccine 2008;26:5241-3. [DOI: 10.1016/j.vaccine.2008.07.049] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]